Cormedix Inc (CRMD)

0.39
0.01 2.20
AMEX : Health Care
Prev Close 0.38
Open 0.40
Day Low/High 0.38 / 0.40
52 Wk Low/High 1.15 / 4.54
Volume 96.41K
Avg Volume 436.30K
Exchange AMEX
Shares Outstanding 59.34M
Market Cap 24.92M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pacific Premier Bancorp, Inc. Announces The Appointment Of New Director

Pacific Premier Bancorp, Inc. Announces The Appointment Of New Director

Pacific Premier Bancorp, Inc. (NASDAQ: PPBI) (the "Company", "Pacific Premier", "we", "us" or "our"), the holding company of Pacific Premier Bank ("Pacific Premier Bank"), announced today the expansion of its Board of...

4 Stocks Under $10 to Trade for Big Breakouts

4 Stocks Under $10 to Trade for Big Breakouts

These stocks under $10 are within range of triggering breakout trades.

Law Offices Of Howard G. Smith Reminds Investors: Two Days Left To File Lead Plaintiff Motion In The Class Action Lawsuit Against CorMedix, Inc.

Law Offices Of Howard G. Smith Reminds Investors: Two Days Left To File Lead Plaintiff Motion In The Class Action Lawsuit Against CorMedix, Inc.

Law Offices of Howard G. Smith reminds investors of the September 4, 2015 lead plaintiff deadline in the class action lawsuit filed on behalf of a class comprising purchasers of the securities of CorMedix, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CorMedix, Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. And Encourages Investors To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey against CorMedix, Inc.

GPM Reminds Investors Of The September 4, 2015 Deadline In The Class Action Lawsuit On Behalf Of CorMedix, Inc. Investors

GPM Reminds Investors Of The September 4, 2015 Deadline In The Class Action Lawsuit On Behalf Of CorMedix, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") reminds investors that a class action lawsuit has been filed on behalf of investors of CorMedix, Inc.

GPM Announces The Filing Of A Securities Class Action On Behalf Of CorMedix, Inc. Investors

GPM Announces The Filing Of A Securities Class Action On Behalf Of CorMedix, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces the filing of a class action lawsuit on behalf of investors of CorMedix, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CorMedix, Inc.

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

CorMedix Stock Sees Short Interest Expand By 40%

CorMedix Stock Sees Short Interest Expand By 40%

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 1,754,347 share increase in total short interest for CorMedix Inc , to 6,132,421, an increase of 40.07% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting CRMD Put And Call Options For March 2016

Interesting CRMD Put And Call Options For March 2016

Investors in CorMedix Inc saw new options become available this week, for the March 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors Of The Important Deadline In The Class Action

TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors Of The Important Deadline In The Class Action

The Rosen Law Firm, a global investor rights firm, reminds purchasers of CorMedix, Inc.

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. To Recover Investor Losses

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. To Recover Investor Losses

The Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of CorMedix, Inc.

CRMD INVESTOR ALERT: Investigation Of CorMedix, Inc., Announced By Glancy Prongay & Murray LLP

CRMD INVESTOR ALERT: Investigation Of CorMedix, Inc., Announced By Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP announces that it is investigating potential claims on behalf of investors of CorMedix, Inc.

Cormedix (CRMD): Today's Weak On High Volume Stock

Cormedix (CRMD): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Cormedix (CRMD) as a weak on high relative volume candidate

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against CorMedix, Inc. - CRMD

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against CorMedix, Inc. - CRMD

The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of CorMedix, Inc.

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech columnist Adam Feuerstein answers readers' questions about health care.

CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin

CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin

CorMedix (CRMD) shares are rising after the company said that the FDA gave positive feedback for its catheter lock solution for oncology patients.

Cormedix (CRMD): Today's Weak On High Volume Stock

Cormedix (CRMD): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Cormedix (CRMD) as a weak on high relative volume candidate

Oversold Conditions For CorMedix (CRMD)

Oversold Conditions For CorMedix (CRMD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Cormedix (CRMD) as a weak on high relative volume candidate

Strong On High Relative Volume: Cormedix (CRMD)

Strong On High Relative Volume: Cormedix (CRMD)

Trade-Ideas LLC identified Cormedix (CRMD) as a strong on high relative volume candidate

January 2017 Options Now Available For CorMedix (CRMD)

January 2017 Options Now Available For CorMedix (CRMD)

Investors in CorMedix Inc saw new options begin trading today, for the January 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 610 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Cormedix (CRMD) as a weak on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BAK, BWC, ENDP, FNBC, GBLI, HAYN, MEET, NAT, TGI Downgrades: AAME, CUDA, DDD, DNR, DRC, ELGX, FMC, GTN, MGCD, NMRX, RKUS, SHLO, TPC Initiations: ALLY, CHMI, CRMD, ENBL, EVDY, FPI, LQ, QURE, TWOU Read on to get TheStreet Quant Ratings' detailed report:

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

The Top-Performing Biotech Stock During a Sizzling First Quarter

The Top-Performing Biotech Stock During a Sizzling First Quarter

That was one crazy first quarter for the biotech sector. Here's where biotech stocks stand on April Fool's Day.

Interesting CRMD Call Options For May 15th

Interesting CRMD Call Options For May 15th

Investors in CorMedix Inc saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRMD options chain for the new May 15th contracts and identified the following call contract of particular interest.